John Oyler, Co-founder, Chairman and CEO at BeOne Medicines, discusses the company's business strategy and the outlook for the biotech sector. He speaks with Avril Hong and Paul Allen from the sidelines of the JPMorgan Healthcare Conference in San Francisco. (Source: Bloomberg)